• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

“慢性偏头痛”患者何时应被视为对药物预防性治疗“难治”?

When should "chronic migraine" patients be considered "refractory" to pharmacological prophylaxis?

作者信息

D'Amico Domenico, Leone Massimo, Grazzi Licia, Bussone Gennaro

机构信息

Department of Clinical Neurosciences, C. Besta Neurological Institute, Via Celoria 11, 20133 Milan, Italy.

出版信息

Neurol Sci. 2008 May;29 Suppl 1:S55-8. doi: 10.1007/s10072-008-0888-3.

DOI:10.1007/s10072-008-0888-3
PMID:18545898
Abstract

Patients with chronic headache forms evolving from a previous episodic migraine ('chronic migraine') are often difficult to treat. In this paper we focus attention on aspects we believe important for producing a definition of "refractory" in relation to this headache form. We propose a "chronic migraine" patient should be considered "refractory" to pharmacological prophylaxis when adequate trials of preventive therapies at adequate doses have failed to reduce headache frequency and improve headache-related disability and, in patients with medication overuse, reduce the consumption of symptomatic drugs. However before a definition of "refractory" chronic migraine can become established, generally accepted diagnostic criteria and treatment guidelines for this condition need to be developed.

摘要

由先前发作性偏头痛演变而来的慢性头痛形式(“慢性偏头痛”)患者通常难以治疗。在本文中,我们将注意力集中在我们认为对于针对这种头痛形式给出“难治性”定义很重要的方面。我们提议,当以适当剂量进行的预防性治疗充分试验未能降低头痛频率、改善与头痛相关的残疾,并且对于药物过度使用的患者未能减少对症药物的消耗量时,“慢性偏头痛”患者应被视为对药物预防“难治”。然而,在“难治性”慢性偏头痛的定义确立之前,需要制定针对这种病症的普遍接受的诊断标准和治疗指南。

相似文献

1
When should "chronic migraine" patients be considered "refractory" to pharmacological prophylaxis?“慢性偏头痛”患者何时应被视为对药物预防性治疗“难治”?
Neurol Sci. 2008 May;29 Suppl 1:S55-8. doi: 10.1007/s10072-008-0888-3.
2
Clinical considerations on chronic migraine, pharmacoresistance and refractoriness.慢性偏头痛的临床思考:药物抵抗和难治性。
Neurol Sci. 2010 Jun;31 Suppl 1:S83-5. doi: 10.1007/s10072-010-0294-5.
3
[Chronic and Refractory Migraine: How to Diagnose and Treat].[慢性和难治性偏头痛:如何诊断与治疗]
Acta Med Port. 2020 Nov 2;33(11):753-760. doi: 10.20344/amp.12004.
4
Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.托吡酯可减少慢性偏头痛的头痛天数:一项随机、双盲、安慰剂对照研究。
Cephalalgia. 2007 Jul;27(7):814-23. doi: 10.1111/j.1468-2982.2007.01326.x. Epub 2007 Apr 18.
5
Defining refractory migraine and refractory chronic migraine: proposed criteria from the Refractory Headache Special Interest Section of the American Headache Society.难治性偏头痛和难治性慢性偏头痛的定义:美国头痛协会难治性头痛特别兴趣小组提出的标准
Headache. 2008 Jun;48(6):778-82. doi: 10.1111/j.1526-4610.2008.01132.x. Epub 2008 May 14.
6
European headache federation consensus on the definition of resistant and refractory migraine : Developed with the endorsement of the European Migraine & Headache Alliance (EMHA).欧洲头痛联合会关于耐药性和难治性偏头痛定义的共识:在欧洲偏头痛和头痛联盟(EMHA)的支持下制定。
J Headache Pain. 2020 Jun 16;21(1):76. doi: 10.1186/s10194-020-01130-5.
7
Medication overuse and chronic migraine: a critical review according to clinical pharmacology.药物过度使用与慢性偏头痛:基于临床药理学的批判性综述
Expert Opin Drug Metab Toxicol. 2015 Jul;11(7):1127-44. doi: 10.1517/17425255.2015.1043265. Epub 2015 May 31.
8
Episodic and chronic migraine headache: breaking down barriers to optimal treatment and prevention.发作性和慢性偏头痛:打破优化治疗与预防的障碍
Headache. 2015 Mar;55 Suppl 2:103-22; quiz 123-6. doi: 10.1111/head.12505_2.
9
Fremanezumab: a disease-specific option for the preventive treatment of migraine, including difficult-to-treat migraine.瑞美吉泮单抗:一种用于偏头痛预防性治疗的疾病特异性药物,包括难治性偏头痛。
Emerg Top Life Sci. 2020 Sep 8;4(2):179-190. doi: 10.1042/ETLS20200018.
10
Rehabilitating chronic migraine complicated by medication overuse headaches: how can we prevent migraine relapse?慢性偏头痛合并药物过度使用性头痛的康复:如何预防偏头痛复发?
Intern Emerg Med. 2011 Feb;6(1):23-8. doi: 10.1007/s11739-010-0410-9. Epub 2010 May 22.

引用本文的文献

1
Breaking the cycle: unraveling the diagnostic, pathophysiological and treatment challenges of refractory migraine.打破循环:揭示难治性偏头痛的诊断、病理生理及治疗挑战
Front Neurol. 2023 Sep 27;14:1263535. doi: 10.3389/fneur.2023.1263535. eCollection 2023.
2
Decompression Surgery for Frontal Migraine Headache.前额偏头痛的减压手术
Plast Reconstr Surg Glob Open. 2020 Oct 15;8(10):e3084. doi: 10.1097/GOX.0000000000003084. eCollection 2020 Oct.
3
European headache federation consensus on the definition of resistant and refractory migraine : Developed with the endorsement of the European Migraine & Headache Alliance (EMHA).

本文引用的文献

1
Risk factors for headache chronification.头痛慢性化的危险因素。
Headache. 2008 Jan;48(1):16-25. doi: 10.1111/j.1526-4610.2007.00970.x.
2
The impact of topiramate on health-related quality of life indicators in chronic migraine.托吡酯对慢性偏头痛患者健康相关生活质量指标的影响。
Headache. 2007 Nov-Dec;47(10):1398-408. doi: 10.1111/j.1526-4610.2007.00950.x.
3
Disability in chronic migraine with medication overuse: treatment effects at 3 years.
Headache. 2007 Oct;47(9):1277-81. doi: 10.1111/j.1526-4610.2007.00861.x.
欧洲头痛联合会关于耐药性和难治性偏头痛定义的共识:在欧洲偏头痛和头痛联盟(EMHA)的支持下制定。
J Headache Pain. 2020 Jun 16;21(1):76. doi: 10.1186/s10194-020-01130-5.
4
Surgical intervention for chronic migraine headache: A systematic review.慢性偏头痛的手术干预:一项系统评价。
JPRAS Open. 2019 Jan 16;20:1-18. doi: 10.1016/j.jpra.2019.01.002. eCollection 2019 Jun.
5
Treatment of the Patient with Refractory Headache.难治性头痛患者的治疗。
Curr Pain Headache Rep. 2018 Mar 19;22(4):23. doi: 10.1007/s11916-018-0677-5.
6
Transcutaneous supraorbital neurostimulation for the prevention of chronic migraine: a prospective, open-label preliminary trial.经皮眶上神经刺激预防慢性偏头痛:一项前瞻性、开放标签的初步试验。
Neurol Sci. 2017 May;38(Suppl 1):201-206. doi: 10.1007/s10072-017-2916-7.
7
A comparison of outcome of medical and surgical treatment of migraine headache: In 1 year follow-up.偏头痛药物治疗与手术治疗效果比较:1年随访
Adv Biomed Res. 2016 Jul 29;5:121. doi: 10.4103/2277-9175.186994. eCollection 2016.
8
Refractory chronic migraine: a consensus statement on clinical definition from the European Headache Federation.难治性慢性偏头痛:欧洲头痛联盟关于临床定义的共识声明
J Headache Pain. 2014 Aug 28;15(1):47. doi: 10.1186/1129-2377-15-47.
9
Refractory migraine: the role of the physician in assessment and treatment of a problematic disease.难治性偏头痛:医师在评估和治疗疑难疾病中的作用。
Neurol Sci. 2013 May;34 Suppl 1:S109-12. doi: 10.1007/s10072-013-1385-x.
10
Peripheral neuromodulation in chronic migraine.慢性偏头痛的周围神经调节。
Neurol Sci. 2012 May;33 Suppl 1:S29-31. doi: 10.1007/s10072-012-1039-4.
4
Validation of the Migraine-Specific Quality of Life Questionnaire version 2.1 (MSQ v. 2.1) for patients undergoing prophylactic migraine treatment.偏头痛特异性生活质量问卷2.1版(MSQ v. 2.1)在接受偏头痛预防性治疗患者中的效度验证。
Qual Life Res. 2007 Sep;16(7):1231-7. doi: 10.1007/s11136-007-9217-1. Epub 2007 Apr 28.
5
Pharmacological approaches to managing migraine and associated comorbidities--clinical considerations for monotherapy versus polytherapy.偏头痛及相关合并症管理的药理学方法——单药治疗与联合治疗的临床考量
Headache. 2007 Apr;47(4):585-99. doi: 10.1111/j.1526-4610.2007.00760.x.
6
Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.托吡酯可减少慢性偏头痛的头痛天数:一项随机、双盲、安慰剂对照研究。
Cephalalgia. 2007 Jul;27(7):814-23. doi: 10.1111/j.1468-2982.2007.01326.x. Epub 2007 Apr 18.
7
Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.托吡酯治疗慢性偏头痛的疗效与安全性:一项随机、双盲、安慰剂对照试验
Headache. 2007 Feb;47(2):170-80. doi: 10.1111/j.1526-4610.2006.00684.x.
8
Testing the combination beta-blocker plus topiramate in refractory migraine.
Acta Neurol Scand. 2007 Feb;115(2):81-3. doi: 10.1111/j.1600-0404.2006.00772.x.
9
The prophylactic treatment of chronic daily headache.慢性每日头痛的预防性治疗。
Headache. 2006 Nov-Dec;46(10):1552-64. doi: 10.1111/j.1526-4610.2006.00621.x.
10
The comorbidity of headache with other pain syndromes.头痛与其他疼痛综合征的共病情况。
Headache. 2006 Oct;46(9):1416-23. doi: 10.1111/j.1526-4610.2006.00584.x.